SCARB2 and hepatocellular carcinoma: In particular, SCARB2 deletion (Supplementary Fig. 1b) decreased the proliferation (Supplementary Fig. 1c) and invasion (Supplementary Fig. 1d) of HCCLM3 and HepG2 cells and suppressed tumorsphere formation of HCCML3, HepG2, and primary human HCC cells (HCC1#) freshly isolated from patient-derived tumors (Supplementary Fig. 1e).